Clinical outcome of conservatively managed pancreatic intraductal papillary mucinous neoplasms with mural nodules and main duct dilation

[1]  M. Fukayama,et al.  Long-term Risk of Malignancy in Branch Duct Intraductal Papillary Mucinous Neoplasms. , 2019, Gastroenterology.

[2]  Jin‐Young Jang,et al.  Clinical validation of the 2017 international consensus guidelines on intraductal papillary mucinous neoplasm of the pancreas , 2019, Annals of surgical treatment and research.

[3]  M. Takenaka,et al.  Evaluation of efficacy of pancreatic juice cytology for risk classification according to international consensus guidelines in patients with intraductal papillary mucinous neoplasm; a retrospective study. , 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[4]  Annabelle L. Fonseca,et al.  Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?☆ , 2018, Surgery.

[5]  S. Tamiya,et al.  The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines , 2018, Surgery Today.

[6]  A. Scarpa,et al.  Systematic review, meta‐analysis, and a high‐volume center experience supporting the new role of mural nodules proposed by the updated 2017 international guidelines on IPMN of the pancreas , 2018, Surgery.

[7]  M. Falconi,et al.  Meta‐analysis of mortality in patients with high‐risk intraductal papillary mucinous neoplasms under observation , 2018, The British journal of surgery.

[8]  Jin‐Young Jang,et al.  of the pancreas , 2017 .

[9]  S. Chari,et al.  Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis , 2016, Gut.

[10]  M. Al-Haddad,et al.  The Natural History of Main Duct–Involved, Mixed-Type Intraductal Papillary Mucinous Neoplasm: Parameters Predictive of Progression , 2014, Annals of surgery.

[11]  R. Doi,et al.  Natural History of Branch Duct Intraductal Papillary Mucinous Neoplasm With Mural Nodules , 2014, Pancreas.

[12]  M. Falconi,et al.  Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[13]  N. Kawada,et al.  A Natural Course of Main Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas With Lower Likelihood of Malignancy , 2010, Pancreas.

[14]  J. Kleeff,et al.  Pancreatic cancer , 1988, Nature Reviews Disease Primers.

[15]  H. Kocher,et al.  Pancreatic Cancer , 2019, Methods in Molecular Biology.